The global distribution of medical goods has become the primary focus of efforts to keep essential supply chains open during the coronavirus pandemic. As globalization has increased, the world’s supply chains have become substantially more interconnected and goods often have more stages to pass through before reaching the end consumer.
From national lockdowns to closed airspace and borders, Covid-19 has resulted in unprecedented disruption to the mechanics of most economies, regardless of their size or stage of development. In particular, the erection of these barriers has placed a major strain on the world’s supply chains, including essential linkages relating to food and medicines.
Join us for a discussion to learn what these new supply chain dynamics mean for Georgia’s life sciences companies.
- Shay Foley, General Manager, Alcon
- Matt Marshall, Senior Director, General Manager, Flexport, SE Region
- Mary Waters, Deputy Commissioner, International Trade, Georgia Department of Economic Development
- Sanofi Representative
In partnership with: